Methods and systems for providing gender specific pharmaceuticals

Patent metadata

Field	Value
Publication number	US-2016206509-A1
Application number	US-201615071965-A
Country	US
Kind code	A1
Filing date	Mar 16, 2016
Priority date	Jun 15, 2005
Publication date	Jul 21, 2016
Grant date	—

Abstract

The present disclosure provides a system of gender specific pharmaceuticals. The system includes a first package of a pharmaceutical for use by a male and a second package of a pharmaceutical for use by a female. The first package includes at least one male dosage having a first dosage amount, an insert positioned in the first package, the insert including a recommended male dosage and a recommended female dosage that is different than the male dosage, and a male label coupled to the first package, the label including a male gender specifier. The female package includes at least one female dosage having a second dosage amount that is smaller than the first dosage amount, an insert positioned in the first package, the insert including a recommended male dosage and a recommended female dosage that is different than the male dosage, and a female label coupled to the second package, the female label including a female gender specifier, wherein the female gender specifier is different than the male gender specifier.

First claim

What is claimed is:

1 . A method for providing gender specific pharmaceuticals, the method comprising:
providing a first package of a pharmaceutical for use by a male, the first package comprising: at least one male dosage having a first dosage amount; an insert positioned in the first package, the insert including a recommended male dosage and a recommended female dosage that is different than the male dosage; and a male label coupled to the first package, the label including a male gender specifier providing a second package of a pharmaceutical for use by a female, the second package comprising: at least one female dosage having a second dosage amount, wherein the first dosage amount is larger than the second dosage amount; an insert positioned in the first package, the insert including a recommended male dosage and a recommended female dosage that is different than the male dosage; and a female label coupled to the second package, the female label including a female gender specifier, wherein the female gender specifier is different than the male gender specifier.

2 . The method of claim 1 , wherein at least a portion of the female dosage includes a gender specifier.

3 . The method of claim 2 , wherein the gender specifier is a pink color that covers at least a portion of the female dosage.

4 . The method of claim 1 , wherein the at least one male dosage and the at least one female dosage is at least one of an oral medication and an intravenous medication.

5 . The method of claim 4 , wherein the at least one male dosage and the at least one female dosage is at least one of a tablet, capsule, powder, and liquid.

6 . The method of claim 1 , wherein at least a portion of the first package includes a gender specifier.

7 . The method of claim 6 , wherein the gender specifier is a color that is at least one of blue and green.

8 . The method of claim 1 , wherein least a portion of the second package includes a gender specifier.

9 . The method of claim 8 , wherein the gender specifier is a color that is at least one of pink and purple.

10 . The method of claim 1 , wherein at least a portion of the first package includes a male gender specifier that is at least one of blue and green color and wherein at least a portion of the second package includes a female gender specifier that is at least one of pink and purple color.

11 . The method of claim 1 , wherein the insert further comprises a recommended male dosage and a recommended female dosage that is different than the male dosage regardless of weight or body mass index.

12 . The method of claim 1 , wherein at least one of the first and second packages includes an RFID label.

13 . A system of gender specific pharmaceuticals, the system comprising:
a first package of a pharmaceutical for use by a male, the first package comprising: at least one male dosage having a first dosage amount; an insert positioned in the first package, the insert including a recommended male dosage and a recommended female dosage that is different than the male dosage; and a male label coupled to the first package, the label including a male gender specifier; and a second package of a pharmaceutical for use by a female, the second package comprising: at least one female dosage having a second dosage amount that is smaller than the first dosage amount; an insert positioned in the first package, the insert including a recommended male dosage and a recommended female dosage that is different than the male dosage; and a female label coupled to the second package, the female label including a female gender specifier, wherein the female gender specifier is different than the male gender specifier.

14 . The system of claim 13 , wherein at least a portion of the female dosage includes a gender specifier.

15 . The system of claim 14 , wherein the gender specifier is a pink color that covers at least a portion of the female dosage.

16 . The system of claim 13 , wherein the at least one male dosage and the at least one female dosage is at least one of an oral medication and an intravenous medication.

17 . The system of claim 16 , wherein the at least one male dosage and the at least one female dosage is at least one of a tablet, capsule, powder, and liquid.

18 . The system of claim 13 , wherein at least a portion of the first package includes a gender specifier.

19 . The system of claim 18 , wherein the gender specifier is a color that is at least one of blue and green.

20 . The system of claim 13 , wherein least a portion of the second package includes a gender specifier.

21 . The system of claim 20 , wherein the gender specifier is a color that is at least one of pink and purple.

22 . The system of claim 13 , wherein at least a portion of the first package includes a male gender specifier that is at least one of blue and green color and wherein at least a portion of the second package includes a female gender specifier that is at least one of pink and purple color.

23 . The system of claim 13 , wherein at least one of the first and second packages includes an RFID label.

24 . A method for providing gender specific pharmaceuticals, the method comprising:
providing a first package of a pharmaceutical for use by a male, the first package comprising: at least one male dosage having a first dosage amount; and a male label coupled to the first package, the label including a male gender specifier providing a second package of a pharmaceutical for use by a female, the second package comprising: at least one female dosage having a second dosage amount that is different than the first dosage amount; and a female label coupled to the second package, the female label including a female gender specifier, wherein the female gender specifier is different than the male gender specifier.

25 . The method of claim 24 , wherein at least a portion of the first package includes a male gender specifier that is at least one of blue and green color and wherein at least a portion of the second package includes a female gender specifier that is at least one of pink and purple color.

26 . The method of claim 24 , wherein at least a portion of the female dosage includes a gender specifier that is a pink color covering at least a portion of the female dosage.

27 . A system of gender specific pharmaceuticals, the system comprising:
a first package of a pharmaceutical for use by a male, the first package comprising: at least one male dosage having a first dosage amount; and a male label coupled to the first package, the label including a male gender specifier; and a second package of a pharmaceutical for use by a female, the second package comprising: at least one female dosage having a second dosage amount that is different than the first dosage amount; and a female label coupled to the second package, the female label including a female gender specifier, wherein the female gender specifier is different than the male gender specifier.

28 . The system of claim 27 , wherein at least a portion of the first package includes a male gender specifier that is at least one of blue and green color and wherein at least a portion of the second package includes a female gender specifier that is at least one of pink and purple color.

29 . The system of claim 13 , wherein the insert fu

Assignees

• P Tech Llc

Inventors

• Bonutti Peter M

Classifications

• A61F2002/305

  Snap connection · CPC title

• A61F2002/30092

  using shape memory or superelastic materials, e.g. nitinol · CPC title

• A61F2250/0031

  made from both resorbable and non-resorbable prosthetic parts, e.g. adjacent parts · CPC title

• A61F2002/30383

  made by laterally inserting a protrusion, e.g. a rib into a complementarily-shaped groove · CPC title

• A61B90/94

  coded with symbols, e.g. text · CPC title